| Name | Title | Contact Details |
|---|---|---|
Jared Burgess |
Director of Information Technology and Infrastructure | Profile |
Chris Porter |
Director of Information Technology and Infrastructure | Profile |
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs.
Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of end stage kidney disease (ESKD). Pathalys` initial asset is upacicalcet, a novel calcimimetic with the potential to improve the treatment of SHPT in hemodialysis patients. Beyond upacicalcet, Pathalys continues to identify other high priority needs and potential solutions for patients with ESKD. Pathalys is headquartered in Research Triangle Park, North Carolina.
Pique Therapeutics is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Advarra Integrated Solutions enable the safe, ethical, compliant, and efficient development of life-changing therapies.
Since 1958, United Counseling Service has been building a stronger community by empowering individuals and families to live healthy, meaningful lives.